S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
Log in

NASDAQ:LFVN - LifeVantage Stock Price, Forecast & News

$10.30
-0.38 (-3.56 %)
(As of 03/31/2020 04:00 PM ET)
Today's Range
$9.76
Now: $10.30
$10.91
50-Day Range
$7.91
MA: $12.54
$15.86
52-Week Range
$7.75
Now: $10.30
$17.25
Volume202,700 shs
Average Volume100,744 shs
Market Capitalization$147.24 million
P/E Ratio12.88
Dividend YieldN/A
Beta1.1
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs. It also provides skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, and micro-lift serums; and Hair Care System under the TrueScience brand name. The company sells its products through a direct sales model, as well as a network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands, Germany, Spain, and Taiwan. LifeVantage Corporation is headquartered in Sandy, Utah.
Read More

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LFVN
CUSIPN/A
Phone801-432-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$225.96 million
Cash Flow$0.76 per share
Book Value$1.90 per share

Profitability

Net Income$7.43 million

Miscellaneous

Employees220
Market Cap$147.24 million
Next Earnings Date5/6/2020 (Estimated)
OptionableOptionable

Receive LFVN News and Ratings via Email

Sign-up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter.


LifeVantage (NASDAQ:LFVN) Frequently Asked Questions

How has LifeVantage's stock been impacted by COVID-19 (Coronavirus)?

LifeVantage's stock was trading at $11.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, LFVN shares have decreased by 9.2% and is now trading at $10.30. View which stocks have been mosted impacted by Coronavirus.

When is LifeVantage's next earnings date?

LifeVantage is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for LifeVantage.

How were LifeVantage's earnings last quarter?

LifeVantage Corp (NASDAQ:LFVN) released its earnings results on Tuesday, January, 28th. The company reported $0.31 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.16 by $0.15. The company had revenue of $61.24 million for the quarter. LifeVantage had a return on equity of 44.94% and a net margin of 5.12%. View LifeVantage's earnings history.

What guidance has LifeVantage issued on next quarter's earnings?

LifeVantage issued an update on its FY 2020 After-Hours earnings guidance on Tuesday, January, 28th. The company provided earnings per share guidance of 0.74-0.79 for the period, compared to the Thomson Reuters consensus estimate of $0.70. The company issued revenue guidance of $235-245 million, compared to the consensus revenue estimate of $245 million.

Has LifeVantage been receiving favorable news coverage?

Press coverage about LFVN stock has trended positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. LifeVantage earned a news sentiment score of 3.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutLifeVantage.

Who are some of LifeVantage's key competitors?

What other stocks do shareholders of LifeVantage own?

Who are LifeVantage's key executives?

LifeVantage's management team includes the following people:
  • Mr. Darren Jay Jensen, Pres, CEO & Director (Age 50)
  • Mr. Steven R. Fife, Chief Financial Officer (Age 58)
  • Mr. Charles J. Wach, Chief Operating Officer (Age 57)
  • Mr. Kevin McMurray, Gen. Counsel
  • Mr. Ryan Goodwin, Chief Marketing Officer (Age 42)

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

How do I buy shares of LifeVantage?

Shares of LFVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $10.30.

How big of a company is LifeVantage?

LifeVantage has a market capitalization of $147.24 million and generates $225.96 million in revenue each year. The company earns $7.43 million in net income (profit) each year or $0.59 on an earnings per share basis. LifeVantage employs 220 workers across the globe. View additional information about LifeVantage.

What is LifeVantage's official website?

The official website for LifeVantage is http://www.lifevantage.com/.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The company can be reached via phone at 801-432-9000 or via email at [email protected]


MarketBeat Community Rating for LifeVantage (NASDAQ LFVN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  150 (Vote Outperform)
Underperform Votes:  126 (Vote Underperform)
Total Votes:  276
MarketBeat's community ratings are surveys of what our community members think about LifeVantage and other stocks. Vote "Outperform" if you believe LFVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LFVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Featured Article: What is net income?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel